Ameriprise Financial Inc. Decreases Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Ameriprise Financial Inc. reduced its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 90.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,305,860 shares of the health services provider's stock after selling 12,218,119 shares during the quarter. Ameriprise Financial Inc. owned 0.76% of Teladoc Health worth $11,870,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health during the fourth quarter worth $29,000. Lindbrook Capital LLC lifted its holdings in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after buying an additional 1,612 shares during the period. Sterling Capital Management LLC grew its position in shares of Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after buying an additional 4,101 shares during the last quarter. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Teladoc Health during the fourth quarter worth about $60,000. Finally, Generali Investments Management Co LLC acquired a new position in shares of Teladoc Health in the fourth quarter worth approximately $64,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on TDOC shares. Wells Fargo & Company dropped their price target on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 8th. Citigroup lowered their price objective on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Jefferies Financial Group cut their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Bank of America lowered their target price on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a report on Friday, April 11th. Finally, Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Twelve analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Teladoc Health has an average rating of "Hold" and an average target price of $9.71.

Teladoc Health Stock Performance

TDOC stock traded down $0.09 during midday trading on Friday, hitting $6.82. The company's stock had a trading volume of 4,118,390 shares, compared to its average volume of 6,248,706. The stock has a market cap of $1.20 billion, a price-to-earnings ratio of -1.18 and a beta of 1.82. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock's 50-day moving average price is $7.42 and its 200 day moving average price is $9.29. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, equities analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Insider Buying and Selling at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.58% of the company's stock.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.